HTLV-1 Tax-induced NFκB activation is independent of Lys-63-linked-type polyubiquitination

Biochemical and Biophysical Research Communications

Volumn 357, Issue 1, 2007, Pages 225-230

  Gohda, Jin ^a   Irisawa, Masato ^a   Tanaka, Yuetsu ^b   Sato, Shintaro ^c   Ohtani, Kiyoshi ^d   Fujisawa, Jun ichi ^e   Inoue, Jun ichiro ^a  

^a THE UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

HTLV 1; MAP3K; NEMO; NF B; TAK1; Tax; Ubiquitination

Indexed keywords

CYTOKINE; I KAPPA B; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; PROTEIN; PROTEIN TPL2; TAX PROTEIN; TUMOR PROGRESSION LOCUS 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; MOUSE; NONHUMAN; PRIORITY JOURNAL; T CELL LEUKEMIA; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UBIQUITINATION; VIRUS CELL TRANSFORMATION;

HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; I-KAPPA B KINASE; JURKAT CELLS; LYSINE; NF-KAPPA B; SIGNAL TRANSDUCTION; UBIQUITIN;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 34147176472     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.03.125     Document Type: Article

References (26)

1. Yoshida M. Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene 24 (2005) 5931-5937
2. Sun S.C., and Yamaoka S. Activation of NF-kappaB by HTLV-I and implications for cell transformation. Oncogene 24 (2005) 5952-5964
3. Robek M.D., and Ratner L. Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J. Virol. 73 (1999) 4856-4865
4. Algarte M., Lecine P., Costello R., Plet A., Olive D., and Imbert J. In vivo regulation of interleukin-2 receptor alpha gene transcription by the coordinated binding of constitutive and inducible factors in human primary T cells. EMBO J. 14 (1995) 5060-5072
5. Yamaoka S., Courtois G., Bessia C., Whiteside S.T., Weil R., Agou F., Kirk H.E., Kay R.J., and Israel A. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 93 (1998) 1231-1240
6. Jeong S.J., Radonovich M., Brady J.N., and Pise-Masison C.A. HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity. Blood 104 (2004) 1490-1497
7. Mori N., Yamada Y., Ikeda S., Yamasaki Y., Tsukasaki K., Tanaka Y., Tomonaga M., Yamamoto N., and Fujii M. Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood 100 (2002) 1828-1834
8. Deng L., Wang C., Spencer E., Yang L., Braun A., You J., Slaughter C., Pickart C., and Chen Z.J. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103 (2000) 351-361
9. Kanayama A., Seth R.B., Sun L., Ea C.K., Hong M., Shaito A., Chiu Y.H., Deng L., and Chen Z.J. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol. Cell 15 (2004) 535-548
10. Zhou H., Wertz I., O'Rourke K., Ultsch M., Seshagiri S., Eby M., Xiao W., and Dixit V.M. Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature 427 (2004) 167-171
11. Sun L., Deng L., Ea C.K., Xia Z.P., and Chen Z.J. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 14 (2004) 289-301
12. Ninomiya-Tsuji J., Kishimoto K., Hiyama A., Inoue J., Cao Z., and Matsumoto K. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398 (1999) 252-256
13. Xu X., Heidenreich O., Kitajima I., McGuire K., Li Q., Su B., and Nerenberg M. Constitutively activated JNK is associated with HTLV-1 mediated tumorigenesis. Oncogene 13 (1996) 135-142
14. Jin G., Klika A., Callahan M., Faga B., Danzig J., Jiang Z., Li X., Stark G.R., Harrington J., and Sherf B. Identification of a human NF-kappaB-activating protein, TAB3. Proc. Natl. Acad. Sci. USA 101 (2004) 2028-2033
15. Trompouki E., Hatzivassiliou E., Tsichritzis T., Farmer H., Ashworth A., and Mosialos G. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424 (2003) 793-796
16. Brummelkamp T.R., Nijman S.M., Dirac A.M., and Bernards R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424 (2003) 797-801
17. Kovalenko A., Chable-Bessia C., Cantarella G., Israel A., Wallach D., and Courtois G. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 424 (2003) 801-805
18. Carter R.S., Pennington K.N., Arrate P., Oltz E.M., and Ballard D.W. Site-specific monoubiquitination of IkappaB kinase IKKbeta regulates its phosphorylation and persistent activation. J. Biol. Chem. 280 (2005) 43272-43279
19. Zetoune F.S., Murthy A.R., Shao Z., Hlaing T., Zeidler M.G., Li Y., and Vincenz C. A20 inhibits NF-kappa B activation downstream of multiple Map3 kinases and interacts with the I kappa B signalosome. Cytokine 15 (2001) 282-298
20. Wertz I.E., O'Rourke K.M., Zhou H., Eby M., Aravind L., Seshagiri S., Wu P., Wiesmann C., Baker R., Boone D.L., Ma A., Koonin E.V., and Dixit V.M. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signaling. Nature 430 (2004) 694-699
21. Nasr R., Chiari E., El-Sabban M., Mahieux R., Kfoury Y., Abdulhay M., Yazbeck V., Hermine O., de The H., Pique C., and Bazarbachi A. Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-kappaB activation. Blood 107 (2006) 4021-4029
22. Carter R.S., Geyer B.C., Xie M., Acevedo-Suarez C.A., and Ballard D.W. Persistent activation of NF-kappa B by the tax transforming protein involves chronic phosphorylation of IkappaB kinase subunits IKKbeta and IKKgamma. J. Biol. Chem. 276 (2001) 24445-24448
23. Symons A., Beinke S., and Ley S.C. MAP kinase kinase kinases and innate immunity. Trends Immunol. 27 (2006) 40-48
24. Yin M.J., Christerson L.B., Yamamoto Y., Kwak Y.T., Xu S., Mercurio F., Barbosa M., Cobb M.H., and Gaynor R.B. HTLV-I Tax protein binds to MEKK1 to stimulate IkappaB kinase activity and NF-kappaB activation. Cell 93 (1998) 875-884
25. Uhlik M., Good L., Xiao G., Harhaj E.W., Zandi E., Karin M., and Sun S.C. NF-kappaB-inducing kinase and IkappaB kinase participate in human T-cell leukemia virus I Tax-mediated NF-kappaB activation. J. Biol. Chem. 273 (1998) 21132-21136
26. Babu G., Waterfield M., Chang M., Wu X., and Sun S.C. Deregulated activation of oncoprotein kinase Tpl2/Cot in HTLV-I-transformed T cells. J. Biol. Chem. 281 (2006) 14041-14047